International journal of clinical practice
-
Int. J. Clin. Pract. · Jul 2013
Comparative StudyMirabegron for the treatment of overactive bladder: a prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double-blind, placebo-controlled, phase III studies.
To examine pooled efficacy data from three, large phase III studies comparing mirabegron (50 and 100 mg) with placebo, and pooled safety data including additional mirabegron 25 mg and tolterodine extended release (ER) 4 mg results. ⋯ The efficacy and safety of mirabegron are demonstrated in this large pooled clinical trial dataset in patients with OAB.